Nathan Singh
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 36
- CAR-T cell therapy research 34
- Cancer Immunotherapy and Biomarkers 2
-
- Acute Myeloid Leukemia Research 1
- Co-authors
- Carl H. June (9 shared papers)Stephan A. Grupp (9 shared papers)David M. Barrett (5 shared papers)Michael J. Mitchell (1 shared paper)Pranali Ravikumar (1 shared paper)Margaret M. Billingsley (1 shared paper)Rui Zhang (1 shared paper)David Maxwell Barrett (4 shared papers)
- Journals
- Blood (3 papers)Cancer Immunology Research (3 papers)Blood Advances (3 papers)Cancer Discovery (2 papers)Cytotherapy (2 papers)
- Partner nations
- United StatesGermanyIsrael
In The Last Decade
Nathan Singh
43 papers receiving 2.8k citations
Nathan Singh's Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 1.8k
- Immunology 398
- Biomaterials 111
- Molecular Biology 508
- Reproductive Medicine 82
Countries citing papers authored by Nathan Singh
This map shows the geographic impact of Nathan Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Singh more than expected).
Fields of papers citing papers by Nathan Singh
This network shows the impact of papers produced by Nathan Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Singh. The network helps show where Nathan Singh may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering Hit paper breakdown → | 2020 | 541 |
| 2 | An NK-like CAR T cell transition in CAR T cell dysfunction Hit paper breakdown → | 2021 | 312 |
| 3 | 2013 | 304 | |
| 4 | 2016 | 270 | |
| 5 | 2020 | 241 | |
| 6 | 2021 | 149 | |
| 7 | 2017 | 133 | |
| 8 | 2014 | 120 | |
| 9 | 2010 | 117 | |
| 10 | 2014 | 82 | |
| 11 | 2014 | 69 | |
| 12 | 2017 | 69 | |
| 13 | 2016 | 62 | |
| 14 | 2022 | 55 | |
| 15 | 2023 | 40 | |
| 16 | 2015 | 39 | |
| 17 | 2019 | 37 | |
| 18 | 2015 | 34 | |
| 19 | 2023 | 32 | |
| 20 | 2009 | 29 |
About Nathan Singh
Nathan Singh is a scholar working on Oncology, Hematology, Rheumatology, Immunology and Emergency Medicine, having authored 45 papers that have together received 2.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (34 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immunotherapy and Immune Responses (2 papers), RNA Interference and Gene Delivery (1 paper), Folate and B Vitamins Research (1 paper), Acute Myeloid Leukemia Research (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper) and Radiation Dose and Imaging (1 paper). The work is most often cited by research in Oncology (1.8k citations), Immunology (398 citations), Biomaterials (111 citations), Molecular Biology (508 citations) and Reproductive Medicine (82 citations). Nathan Singh has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Carl H. June, Stephan A. Grupp, David M. Barrett, Michael J. Mitchell, Pranali Ravikumar, Margaret M. Billingsley, Rui Zhang, David Maxwell Barrett, Jessica Perazzelli and David L. Porter. Their work appears in journals such as Blood, Cancer Immunology Research, Blood Advances, Cancer Discovery and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.